Hui‐Ling Chen
- Hepatology top 2%
- Liver physiology and pathology 12
- Cancer Research top 5%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 7
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 15
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 9
- Cancer-related Molecular Pathways 6
-
- Organ Transplantation Techniques and Outcomes 13
- Pediatric Hepatobiliary Diseases and Treatments 7
-
- Genetic Syndromes and Imprinting 5
Hui‐Ling Chen
163 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 150
- Hepatology 466
- Cancer Research 576
- Molecular Biology 1.9k
- Epidemiology 814
- Oncology 627
Countries citing papers authored by Hui‐Ling Chen
This map shows the geographic impact of Hui‐Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ling Chen more than expected).
Fields of papers citing papers by Hui‐Ling Chen
This network shows the impact of papers produced by Hui‐Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ling Chen. The network helps show where Hui‐Ling Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui‐Ling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2022 | 27 | |
| 4 | Superantigens, superantigen-like proteins and superantigen derivatives for cancer treatment | 2021 | 7 |
| 5 | 2021 | 34 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 1 | |
| 8 | 2018 | 12 | |
| 9 | 2013 | 6 | |
| 10 | 2012 | 41 | |
| 11 | 2009 | 39 | |
| 12 | 2009 | 13 | |
| 13 | 2009 | 62 | |
| 14 | Geochemical characteristics and ~(40)Ar-~(39)Ar ages of the amphibolites and gabbros in Tarlang area:implications for tectonic evolution of the Chinese Altai. | 2007 | 8 |
| 15 | 2005 | 136 | |
| 16 | 2005 | 80 | |
| 17 | 2003 | 125 | |
| 18 | 1998 | 41 | |
| 19 | 1993 | 20 | |
| 20 | 1988 | 3 |
About Hui‐Ling Chen
Hui‐Ling Chen is a scholar working on Hepatology, Toxicology, Virology, Oncology and Epidemiology, having authored 167 papers that have together received 4.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (15 papers), Organ Transplantation Techniques and Outcomes (13 papers), Liver physiology and pathology (12 papers), Drug Transport and Resistance Mechanisms (9 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related Molecular Pathways (6 papers) and Genetic Syndromes and Imprinting (5 papers). The work is most often cited by research in Hepatology (466 citations), Cancer Research (576 citations), Molecular Biology (1.9k citations), Epidemiology (814 citations) and Oncology (627 citations). Hui‐Ling Chen has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Pei‐Jer Chen, Ann‐Lii Cheng, Kuen‐Feng Chen, Mei‐Hwei Chang, Wei‐Tien Tai, Huey‐Ling Chen, Shao‐Chun Lu, Chih‐Hung Hsu, Ding‐Shinn Chen and Wen-Chi Feng. Their work appears in journals such as Journal of Biomedical Science, PLoS ONE, Journal of Biological Chemistry, Acta Pharmacologica Sinica and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.